バイオフィルム処理市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00015873
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 200
Buy Now

バイオフィルム処理市場は、2019 年に 15 億 9,031 万米ドルと評価され、2027 年までに 28 億 2,580 万米ドルに達すると予測されています。 2020 年から 2027 年にかけて 7.5% の CAGR で成長すると予想されています。



バイオフィルムは、真菌、細菌、酵母、藻類、その他の微生物の混合株で構成されています。バイオフィルムは、特定の種類の細菌または真菌が創傷表面に付着し、その上にマトリックスを形成すると、創傷表面に発生します。不快な臭いを伴う粘稠で光沢のある物質が分泌されます。世界中で糖尿病症例の増加、火傷や潰瘍による皮膚損傷の発生率の増加、外科手術件数の増加がバイオフィルム治療市場の成長を加速させています。さらに、創傷治療製品におけるイノベーションの数の増加により、予測期間中に市場の成長が促進されると予想されます。しかし、創傷ケア管理に関連する高額なコストがバイオフィルム治療市場の成長を妨げています。



バイオフィルム治療市場の有利な地域



市場洞察



発生率の増加創傷および潰瘍の治療



糖尿病性足潰瘍や褥瘡など、糖尿病に関連するリスクの高まりにより、高度な生物活性創傷ケア管理製品の需要が加速しています。さらに、抗菌薬耐性、不健康なライフスタイル、アルコール摂取、喫煙などの要因により、非感染性疾患の有病率が増加しています。国際糖尿病連盟によると、2019 年には約 4 億 6,300 万人の成人が糖尿病に罹患しており、糖尿病に苦しむ成人患者の数は 2045 年までに 7 億人に達すると予想されています。国際糖尿病連盟によると、糖尿病患者は 15 ~ 40 歳です。下肢切断が必要となる可能性が倍増します。切断の約 85% は、神経障害性足部潰瘍の発症が原因で行われています。



製品ベースの洞察



製品に基づいて、バイオフィルム治療市場はデブリードマン装置、ガーゼと包帯、グラフトとマトリックス、その他の製品。 2019 年には、ガーゼおよびドレッシング部門が市場で最大のシェアを占めました。同じ部門は、予測期間中に市場で最高の CAGR を記録すると予想されます。多くの企業がバイオフィルムを防ぐための高度なドレッシングを開発しています。たとえば、ConvaTec Inc. は、柔らかい吸収性ドレッシング材が創傷液と接触するとゲルを形成するハイドロファイバー技術を開発しました。この技術は細菌が増殖するデッドスペースを減らし、迅速かつ持続的な抗菌作用も提供します。



ガーゼは織物と不織布の形で入手でき、吸収性が高く、感染者と非感染者の両方に適用できます。



世界のバイオフィルム治療市場、製品別 - 2019 年および 2027 年



創傷の種類に基づく洞察



創傷の種類に基づいて、バイオフィルム治療市場は分割されています外傷性創傷や外科的創傷、糖尿病性足潰瘍、褥瘡、静脈性脚潰瘍、その他の創傷に適用されます。外傷および外科的創傷セグメントは、2019年に市場で最大のシェアを占めました。同じセグメントは、予測期間中に市場で最高のCAGRを記録すると予想されます。最も一般的な外傷は、開放骨折、剥離、および貫通性創傷です。 2019年に疾病管理予防センター(CDC)が発表したデータによると、米国では毎年約80万人の患者が股関節損傷で入院している。さらに、約 30 万人の成人患者が股関節骨折により入院しています。 HCUP 統計概要によると、米国では年間総来院数のうち、約 2,200 万件が外傷および事故傷害の治療のために救急部門で来院されていると報告されています。交通事故やスポーツ傷害の増加により、外傷および外科的創傷セグメントの市場成長が促進されています。



エンドユーザーベースの洞察



エンドユーザーに基づいて、バイオフィルム治療市場は分割されています。病院、在宅医療現場、その他のエンドユーザーに提供します。病院セグメントは、2019年に市場で最大のシェアを占めました。また、同じセグメントが、予測期間中に市場で最高のCAGRを記録すると推定されています。このセグメントの市場の成長は、世界中、特に低所得国での熱傷の発生率の増加に起因しています。病院は、怪我の応急処置や治療を求める患者が訪れる主要な医療センターです。一般に、患者は他の医療センターよりもクリニックや病院を訪れることを好みます。これらのセンターは、必要な機器をすぐに利用できるとともに、さまざまなサービスと質の高い治療を提供します。さらに、治療料金は払い戻されます。



戦略的洞察



バイオフィルム治療市場で事業を展開しているさまざまな企業は、製品の発売、合併と買収、コラボレーション、製品イノベーション、



バイオフィルム治療市場 – 製品別




  • ガーゼおよびドレッシング材

  • デブリードマン装置

  • グラフトおよびマトリックス

  • その他の製品


バイオフィルム治療市場 - 創傷タイプ別




  • 外傷および外科的創傷

  • 糖尿病性足潰瘍

  • 褥瘡

  • 静脈性下肢潰瘍

  • その他の創傷

  • li>

バイオフィルム治療市場 - エンドユーザー別




  • 病院

  • 在宅医療環境

  • その他のエンドユーザー

  • >

バイオフィルム処理市場 - 地理別




  • 北米

    • 米国

    • カナダ

    • メキシコ< /li>


  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • 英国

    • スペイン

    • ヨーロッパのその他の地域



  • アジア太平洋(APAC)

    • 中国

    • インド< /li>
    • 韓国

    • 日本

    • オーストラリア

    • アジア太平洋地域のその他の地域



  • 中東アフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • UAE

    • MEA の残りの部分


    < /li>
  • 南アメリカ (SAM)

    • ブラジル

    • アルゼンチン

    • SAM の残りの部分



  • 会社概要




    • Smith & Nephew plc

    • MiMedx Group Inc.

    • ConvaTec Group plc

    • Coloplast A/S

    • Mönlycke Healthcare AB

    • Organogenesis Holdings Inc.

    • Integra LifeSciences Holdings Corporation

    • B. Braun Melsungen AG

    • PAUL HARTMANN AG

    • Medline Industries Inc.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is biofilms treatment?

Biofilms are composed of mixed strains of fungi, bacteria, yeasts, algae, and other microbes. A biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it. Viscous and shiny substances with unpleasant smell are secreted. The rise in several diabetes cases, as well as skin injuries due to burns, is expected to fuel the growth of the biofilms treatment market during the estimated period.

What are the driving factors for the biofilms treatment market across the globe?

The rising diabetes cases, increasing incidence of skin injuries due to burns and ulcers wounds, and growing number of surgical procedures across the world fuel the biofilms treatment market growth. Moreover, the rising number of innovations in wound care products is expected to drive market growth during the forecast period.

What are the factors that are hampering the biofilms treatment market?

The cost of the treatment varies as per the healthcare setting. For instance, the cost of treatment is higher in a hospital than in an outpatient setting. Additionally, the type of dressing or therapy will also have an impact on cost-effectiveness. The high cost associated with wound care management is hampering market growth.

The List of Companies - Biofilms Treatment Market

  1. Smith & Nephew plc
  2. MiMedx Group Inc.
  3. ConvaTec Group plc
  4. Coloplast A/S  
  5. Mölnlycke Healthcare AB
  6. Organogenesis Holdings Inc.
  7. Integra LifeSciences Holdings Corporation
  8. B. Braun Melsungen AG  
  9. PAUL HARTMANN AG
  10. Medline Industries Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports